James E. Ray

717 total citations
19 papers, 574 citations indexed

About

James E. Ray is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, James E. Ray has authored 19 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in James E. Ray's work include Synthetic Organic Chemistry Methods (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Catalytic C–H Functionalization Methods (3 papers). James E. Ray is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Catalytic C–H Functionalization Methods (3 papers). James E. Ray collaborates with scholars based in United States and Canada. James E. Ray's co-authors include John E. Toth, Richard M. Schultz, Thomas A. Engler, Keith D. Combrink, John F. Worzalla, Chuan Shih, Joseph H. Kennedy, Rima Al‐awar, Bryan H. Norman and Jeffrey A. Dodge and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

James E. Ray

19 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Ray United States 13 326 274 94 81 39 19 574
James E. Sheppeck United States 15 296 0.9× 313 1.1× 72 0.8× 72 0.9× 33 0.8× 24 628
Douglas G. Batt United States 18 405 1.2× 274 1.0× 105 1.1× 92 1.1× 10 0.3× 35 803
Matthew E. Voss United States 14 274 0.8× 281 1.0× 26 0.3× 134 1.7× 31 0.8× 22 708
Teruo Oku Japan 17 493 1.5× 339 1.2× 61 0.6× 91 1.1× 12 0.3× 28 911
Francis X. Tavares United States 17 453 1.4× 345 1.3× 71 0.8× 192 2.4× 26 0.7× 34 862
Ashley Fenwick United Kingdom 12 310 1.0× 260 0.9× 91 1.0× 42 0.5× 17 0.4× 19 572
Wanjun Zheng United States 14 358 1.1× 281 1.0× 164 1.7× 194 2.4× 89 2.3× 19 907
Kristi Leonard United States 15 338 1.0× 253 0.9× 36 0.4× 183 2.3× 59 1.5× 24 699
Joseph P. Burkhart United States 18 474 1.5× 399 1.5× 61 0.6× 84 1.0× 32 0.8× 29 887
Shridhar G. Hegde United States 13 502 1.5× 228 0.8× 132 1.4× 40 0.5× 17 0.4× 21 677

Countries citing papers authored by James E. Ray

Since Specialization
Citations

This map shows the geographic impact of James E. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Ray more than expected).

Fields of papers citing papers by James E. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Ray. The network helps show where James E. Ray may publish in the future.

Co-authorship network of co-authors of James E. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Ray. A scholar is included among the top collaborators of James E. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Ray. James E. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liang, Jian, Richard E. Moore, Eric D. Moher, et al.. (2005). Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors. Investigational New Drugs. 23(3). 213–224. 49 indexed citations
2.
Al‐awar, Rima, James E. Ray, Jianping Huang, et al.. (2004). Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(15). 3925–3928. 18 indexed citations
3.
Al‐awar, Rima, James E. Ray, Jianping Huang, et al.. (2004). 1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3217–3220. 23 indexed citations
4.
Faul, Margaret M., Thomas A. Engler, Kevin A. Sullivan, et al.. (2004). Synthetic Approaches to Indolo[6,7-a]pyrrolo[3,4-c]carbazoles:  Potent Cyclin D1/CDK4 Inhibitors. The Journal of Organic Chemistry. 69(9). 2967–2975. 31 indexed citations
5.
Al‐awar, Rima, Thomas H. Corbett, James E. Ray, et al.. (2004). Biological evaluation of cryptophycin 52 fragment A analogues: Effect of the multidrug resistance ATP binding cassette transporters on antitumor activity. Molecular Cancer Therapeutics. 3(9). 1061–1067. 13 indexed citations
6.
Al‐awar, Rima, James E. Ray, Richard M. Schultz, et al.. (2003). A Convergent Approach to Cryptophycin 52 Analogues:  Synthesis and Biological Evaluation of a Novel Series of Fragment A Epoxides and Chlorohydrins. Journal of Medicinal Chemistry. 46(14). 2985–3007. 24 indexed citations
7.
Schmidt, Andrea, Haiping Wu, Robert E. MacKenzie, et al.. (2000). Structures of Three Inhibitor Complexes Provide Insight into the Reaction Mechanism of the Human Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase. Biochemistry. 39(21). 6325–6335. 46 indexed citations
8.
Patel, Vinod F., Sherri L. Andis, Joseph H. Kennedy, James E. Ray, & Richard M. Schultz. (1999). Novel Cryptophycin Antitumor Agents:  Synthesis and Cytotoxicity of Fragment “B” Analogues. Journal of Medicinal Chemistry. 42(14). 2588–2603. 33 indexed citations
9.
Tonkinson, John L., Lillian L. Habeck, John E. Toth, et al.. (1998). The Antiproliferative and Cell Cycle Effects of 5,6,7,8-Tetrahydro-N5,N10-Carbonylfolic Acid, an Inhibitor of Methylenetetrahydrofolate Dehydrogenase, Are Potentiated by Hypoxanthine. Journal of Pharmacology and Experimental Therapeutics. 287(1). 315–321. 11 indexed citations
10.
Toth, John E., Gerald B. Grindey, William J. Ehlhardt, et al.. (1997). Sulfonimidamide Analogs of Oncolytic Sulfonylureas,1. Journal of Medicinal Chemistry. 40(6). 1018–1025. 90 indexed citations
11.
Ehlhardt, William J., et al.. (1997). Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat, and monkey.. PubMed. 25(6). 701–8. 8 indexed citations
12.
Norman, Bryan H., Chuan Shih, John E. Toth, et al.. (1996). Studies on the Mechanism of Phosphatidylinositol 3-Kinase Inhibition by Wortmannin and Related Analogs. Journal of Medicinal Chemistry. 39(5). 1106–1111. 103 indexed citations
13.
Engler, Thomas A., et al.. (1994). Stereospecific Lewis Acid-Promoted Reactions of Styrenyl Systems with 2-Alkoxy-(6-Alkyl)-1,4-Benzoquinones: Scope, Limitations, and Synthetic Applications. The Journal of Organic Chemistry. 59(22). 6567–6587. 48 indexed citations
14.
Ray, James E., et al.. (1993). Cleavage of chiral 4-phenyl-2-oxalidinones with TMSI: Application to the synthesis of carbacephems. Tetrahedron Letters. 34(30). 4755–4758. 16 indexed citations
15.
Toth, John E., James E. Ray, & Jack B. Deeter. (1993). Synthesis and resolution of sulfonimidamide analogs of sulfonylureas. The Journal of Organic Chemistry. 58(12). 3469–3472. 10 indexed citations
16.
Toth, John E., et al.. (1992). The synthesis of o-aminophenyl sulfate metabolites of the oncolytic sulfonylureas. Bioorganic & Medicinal Chemistry Letters. 2(9). 1013–1014. 2 indexed citations
17.
Ehlhardt, William J., et al.. (1992). Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.. Drug Metabolism and Disposition. 20(6). 958–961. 5 indexed citations
18.
Engler, Thomas A., Keith D. Combrink, & James E. Ray. (1989). An Efficient Method for the Synthesis of 1-Arylalkynes. Synthetic Communications. 19(9-10). 1735–1744. 5 indexed citations
19.
Engler, Thomas A., Keith D. Combrink, & James E. Ray. (1988). Stereoselective 3 + 2 and stereospecific 2 + 2 cycloaddition reactions of alkenes and quinones. Journal of the American Chemical Society. 110(23). 7931–7933. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James E. Sheppeck Breakdown of academic impact, for papers by Douglas G. Batt Breakdown of academic impact, for papers by Matthew E. Voss Breakdown of academic impact, for papers by Teruo Oku Breakdown of academic impact, for papers by Francis X. Tavares Breakdown of academic impact, for papers by Ashley Fenwick Breakdown of academic impact, for papers by Wanjun Zheng Breakdown of academic impact, for papers by Kristi Leonard Breakdown of academic impact, for papers by Joseph P. Burkhart Breakdown of academic impact, for papers by Shridhar G. Hegde
Rankless by CCL
2026